Open Label Extension Study of Bifeprunox

Completed · Phase 3

Conditions studied: Schizophrenia

In brief

A one year extension study using flexible doses, 20 or 30 mg daily, of open-label bifeprunox.

Key facts

Study ID

NCT00366171

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

120

Starts

2006-11-01

Expected to finish

2007-10-01

Last updated by the study team

2007-12-27

Who can join

Age: 18 and older, up to 66. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Outpatients who have successfully completed Wyeth study 3168A1-311-US.
• A signed and dated informed consent form for this study.
• No major protocol violations in previous study.

You may not qualify if…

• Clinically important abnormalities noted in preceding short-term study that have not resolved.
• Use of prohibited treatments in the preceding short-term study.
• Meeting any exclusion criteria for the preceding short-term study.

Where it is running

• Study site — Little Rock, Arkansas, United States
• Study site — Anaheim, California, United States
• Study site — Anaheim, California, United States
• Study site — Anaheim, California, United States
• Study site — Boynton Beach, California, United States
• Study site — Buena Park, California, United States
• Study site — Cerritos, California, United States
• Study site — Costa Mesa, California, United States
• Study site — Costa Mesa, California, United States
• Study site — Escondido, California, United States
• Study site — Garden Grove, California, United States
• Study site — Glendale, California, United States
• Study site — Huntington Beach, California, United States
• Study site — La Mesa, California, United States
• Study site — National City, California, United States
• Study site — Oceanside, California, United States
• Study site — Paramount, California, United States
• Study site — Rosemead, California, United States
• Study site — Sacramento, California, United States
• Study site — San Diego, California, United States
• Study site — San Diego, California, United States
• Study site — San Diego, California, United States
• Study site — Santa Ana, California, United States
• Study site — Santa Ana, California, United States
• Study site — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.